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Abstract 
S-oxidation is a common metabolic route for sulphur containing compounds. When studying 
the fragmentation of some chemically synthesised sulphoxides, two unexpected losses of 
62 m/z units were observed in the collision-induced dissociation (CID) product ion spectrum 
protonated 3-dimethylaminomethyl-4-(4-methanesulfinyl-3-methyl-phenoxy)-
benzenesulfonamide. A single loss was initially assigned using the low resolution product ion 
spectrum, acquired by electrospray ionisation-quadrupole ion trap-mass spectrometry (ESI-
QIT-MS), as methanethial, S-oxide with the dissociation proceeding via a charge-remote, 
four-centred rearrangement. This assignment was consistent with well-documented hydrogen 
rearrangements in the literature. Further, the loss was not observed for the parent compound. 
Thus, it was inferred that the site of metabolism was involved in the dissociation and the 
attractive nature of the four-centred rearrangement meant that the loss of methanethial, S-
oxide was a logical assignment. However, deuterium labelling experiments and accurate mass 
measurements, performed using electrospray ionisation-Fourier Transform Ion Cyclotron 
Resonance-mass spectrometry (ESI-FTICR-MS), showed that two distinct losses of 62 m/z 
units occur, neither of which was of that initially hypothesised from the low resolution 
product ion spectrum of the protonated molecule. Mechanisms consistent with the 
experimental findings are postulated. An MS3 spectrum of the fully exchanged, deuterated 
species supported the proposed mechanisms by suggesting that 3-dimethylaminomethyl-4-(4-
methanesulfinyl-3-methyl-phenoxy)-benzenesulfonamide has multiple sites of protonation in 
the gas phase. The planar structures of the posited product ions are likely to provide the 
driving force for the rearrangements. The relevance of the observations with regards to 
pharmaceutical drug metabolite identification are discussed. 
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Identification of the metabolites of pharmaceutical compounds is a key stage of drug 
discovery. Sites on the novel chemical entity prone to biotransformation are identified, thus 
allowing the pharmacokinetic behaviour of the molecule to be improved through alteration of 
the compound’s structure.1, 2 Active metabolites, i.e. those possessing pharmacological 
activity similar, synergistic or inhibitory to that of the parent compound, can be identified to 
rationalise pharmacodynamic results.3, 4 Additionally, novel chemical entities that form 
reactive metabolites, resulting in toxicity, can be identified and either modified or eliminated 
to prevent failure of the drug candidate in the development stage.5 
 
During early drug discovery metabolite identification studies, limited amounts of chemical 
bulk and the need for liquid chromatographic separation may prohibit the routine acquisition 
of nuclear magnetic resonance (NMR) spectra for definitive structural elucidation. Hence, 
mass spectrometry is routinely used to assign the sites of metabolism of pharmaceutical drug 
compounds. The principal method involves comparing the collision-induced dissociation 
(CID) product ion spectrum of the parent compound with that of the metabolite and looking 
for mass shifts of the major peaks in these spectra to determine which part of the molecule 
has been altered i.e. the Shift technique.6 However, unambiguous assignments by this 
approach are frequently not possible, particularly for oxidised metabolites where the 
biotransformation can take place at carbon, nitrogen or sulfur atoms; all common constituents 
of pharmaceutical compounds.7 Furthermore, the high-throughput nature of modern drug 
discovery means that multiple mass spectrometric-related structural elucidation experiments 
e.g. deuterium labelling, derivatisation etc., are rarely performed. Thus, there is a risk that 
incorrect assignment of sites of metabolism could arise. This is a particular likelihood given 
that the CID processes for molecules of this type are still not fully understood, with 
unexpected rearrangements under CID conditions being previously reported in the literature 
for both small and peptidic molecules.8-11 Herein, a further example of unanticipated 
dissociation behaviour, observed for the model sulfoxide detailed here, demonstrates how 
incorrect assignment of the sites of metabolism of a novel chemical entity could occur if a 









benzenesulfonamide (2) were synthesised by Pfizer Global Research and Development 
(Sandwich, UK). Reserpine was purchased from Sigma-Aldrich Company Limited 
(Gillingham, Dorset, UK). Solutions were prepared in LC-MS grade methanol and analytical 
grade methanoic acid [99.9:0.1, v/v] (Fisher Scientific UK Limited, Loughborough, UK). 
Solutions of 1 and 2 were prepared at 10 µg mL-1 for the quadrupole ion trap mass 
spectrometry (QIT-MS) experiments. Further solutions of 1 were prepared at 1 µg mL-1 for 
the Fourier transform ion cyclotron resonance-mass spectrometry (FT-ICR-MS) experiments 
and 10 µg mL-1 in >99.5% deuterated methanol and 99.5% deuterated ethanoic acid 
[99:1, v/v] (Apollo Scientific Limited, Stockport, UK) for hydrogen/deuterium (H/D) 
exchange experiments. All chemicals were used without further purification. 
 
Instrumental 
Product ion spectra of either the protonated or fully, exchanged deuterated molecule for each 
compound were acquired using a LCQ Classic QIT mass spectrometer (Thermo Fisher 
Scientific, San Jose, CA, USA). Positive ion electrospray (ESI) was performed by infusing 
the solutions directly into the source at a constant flow rate of 3 µL min-1. Nitrogen was used 
as the sheath and auxiliary gas. The source conditions were; sheath gas, 35 arbitrary units; 
auxiliary gas, 5 arbitrary units; spray voltage, 4.5 kV; capillary voltage, 11 V; capillary 
temperature, 220 oC; tube lens offset, 35 V. Product ion spectra were acquired using an 
isolation width of 6 m/z units (1 m/z unit for the H/D exchange experiments), an activation Q 
of 0.250 and an activation time of 30 msec. The normalised collision energy was set to 50% 
and WideBand activation was switched on. Acquisitions were performed for twenty scans. 
Helium was used as the buffer gas. Data acquisition was performed using XCalibur version 
1.2 (Thermo Fisher Scientific, San Jose, CA, USA). 
 
Accurate mass measurements were performed using an Apex III FT-ICR mass spectrometer 
(Bruker, Billerica, MA, USA) equipped with a 4.7 Tesla actively shielded superconducting 
magnet, an Infinity cylindrical analyser cell and an Apollo ESI source. Positive ion ESI was 
performed by infusing the solutions directly into the source at a constant flow rate of 
3 µL min-1. Nitrogen was used as the drying gas. The source conditions were; capillary 
voltage, -4.5 kV; end plate voltage, -3.8 kV; capillary exit voltage, 100 V; skimmer 1, 11 V; 
skimmer 2, 6 V; Offset, 1.25; Rf amplitude, 600 Hz; dry gas temperature, 250 oC; dry gas 
flow rate, 30 arbitrary units; nebulising gas pressure, 50 psi. The excitation amplitude was 
3.7 dB. The product ion spectra were acquired for eight scans using 1024K data points. 
Argon was used as the collision gas. The MS/MS parameters were; corr sweep pulse length, 
1000 µsec; corr sweep attenuation, 37.5 dB; ejection safety belt, 3000 Hz; user pulse length, 
1000 µsec; ion activation pulse length, 250000 µsec; ion activation attenuation, 37.2 dB; 
frequency offset from activation mass, - 500 Hz; user delay length, 3 sec. The instrument was 
calibrated using the first-generation product ion spectrum of protonated reserpine. The 
calibrant concentration was 100 ng mL-1 and the solution was infused directly into the ESI 
source at a constant flow rate of 3 µL min-1. Data acquisition was performed using XMass 
version 7.0.8 (Bruker, Billerica, MA, USA). 
 
Results and discussion 
During a project to identify product ions and losses that facilitate rapid and definitive 
identification of pharmaceutical drug metabolites, the dissociation of a model S-oxidised 
metabolite, 3-dimethylaminomethyl-4-(4-methanesulfinyl-3-methyl-phenoxy)-
benzenesulfonamide (1) (Figure 1), was investigated. The first generation product ion 
spectrum of the protonated molecule is shown in Figure 2. It was hypothesised that the ion at 
m/z 321 was due to the loss of the methyl sulfoxide group. Thus, the dissociation was thought 
to be of potential use in metabolite identification; the 62 m/z unit loss being assigned as 
methanethial, S-oxide (CH2SO). S-oxidation of the parent compound produces an ideal 
candidate for the loss of 62 m/z units through the well-documented processes of charge-
remote fragmentation12 and 1,3-proton shifts13 via four-centred rearrangements (Figure 3). 
This hypothesis was further attractive due to the absence of the same 62 m/z unit loss from 
the parent compound (data not shown). Thus, it was postulated that the loss involved the 
oxygen atom. The dissociation was thought to be energetically favourable due to the 
conformance of the postulated product ion with the even-electron rule.14 However, the loss 
could not be confirmed by a change in the 34S isotope pattern for the product ion compared to 
the precursor ion due to the difficulties associated with observing the true isotope pattern 
using a QIT mass spectrometer. The overlapping of the A + 2 peak with the peak due to the 
lightest isotopes of the product ion at m/z 323 further precluded this approach to structural 
elucidation. 
 
It was noted that the 62 m/z unit loss involved none of the three exchangeable hydrogen 
atoms on the precursor ion. Thus, if the assignment of the loss was correct, the m/z of the 
product ion would shift by 3 m/z units to m/z 324 in the product ion spectrum of the fully 
exchanged, deuterated species (Figure 4). The absence of a peak at m/z 324 in the deuterated 
sample indicated that the initially posited loss was incorrect. Further, an additional peak was 
observed at m/z 323 in the product ion spectrum of the fully, exchanged deuterated species 
that was not seen for the protonated molecule. It should be noted that this ion was different to 
that seen at m/z 323 in the product ion spectrum of the protonated molecule, which was mass 
shifted to m/z 325 under deuterated conditions. The observation of an additional peak led to 
the deduction that two nominally isobaric product ions were formed through dissociation of 
the protonated species. The product ions only became mass resolved when the fully 
exchanged, deuterated molecule was fragmented due to the retention of different numbers of 
deuterium atoms by the two product ions. Thus, the H/D exchange experiment showed that 
two losses of 62 m/z units took place, neither of which was that initially postulated. The loss 
of all of the deuterium atoms to form the product ion at m/z 321 indicated that the primary 
amine group had been lost during the dissociation. This was because exchange of two 
hydrogen atoms for deuterium labels would have occurred at this functional group. The peak 
at m/z 323, formed through a loss involving one deuterium atom, indicated that this product 
ion retained the primary amine. Further, it suggested that the ionising deuteron was lost 
during the dissociation, and hence the loss included a site of ionisation. 
 
Further experimentation was undertaken to characterise the two losses of 62 m/z units. To this 
end, the first generation product ion spectrum of a deuterium labelled analogue, 3-dimethyl-
2H6-aminomethyl-4-(4-methanesulfinyl-3-methyl-phenoxy)-benzenesulfonamide (2) (Figure 
5), was acquired (Figure 6). In the mass range of interest, the product ion spectrum resembled 
that of protonated 1 with only two peaks being observed. This indicated that the product ions 
were nominally isobaric again and neither product ion retained the six deuterium labels. 
Thus, both losses of 62 m/z units involved the tertiary amine group. The H/D exchange 
experiment had shown that one product ion also lost the primary amine group; thus the 
overall loss was postulated to be C2H10N2. The same experiment had also shown that one 
product ion retained the primary amine and lost the ionising deuteron. From this information, 
it was deduced that the tertiary amine group was a site of protonation. Further, it suggested 
that the remaining loss of 17 m/z units for the product ion that retained the primary amine 
group (62 m/z units minus 45 m/z units for the tertiary amine group plus the ionising proton) 
was likely to be a hydroxyl radical; an overall proposed loss of C2H8NO•. 
 
To confirm the hypothesised losses, accurate mass measurements were performed using 
Fourier transform-ion cyclotron resonance (FT-ICR) mass spectrometry. Figure 7 shows the 
first generation product ion spectrum of protonated 1 in the mass range of interest. The high 
resolving power of the FT-ICR mass spectrometer allowed mass resolution of the two 
nominally isobaric ions at m/z 321. The lowest error elemental formulae, given the precursor 
ion formula, were consistent with those postulated and confirmed that the two losses of 
62 m/z units were C2H10N2 and C2H8NO•. 
 
The verification of the elemental composition of the losses allowed postulation of 
dissociation mechanisms leading to the decomposition of the precursor ion. The ion with an 
elemental formula of C15H13O4S2+ (3) had a ring plus double bond equivalents value of 9.5, 
confirming that it was an even-electron ion.15 Because of the deficiency of this value by 0.5 
due to the addition of a proton to the molecule16, the number of rings plus double bond 
equivalents in the product ion must have been 10. Figure 8 shows a proposed mechanism 
leading to the formation of a product ion which satisfies this value; the double bonds of the 
sulfone group are discounted due to sulfur not being in its lowest valence state.15 Protonation 
is postulated on the primary amine to facilitate the loss of the two exchangeable hydrogen 
atoms as part of a molecule of ammonia. The posited product ion structure is predominately 
planar as evinced by the molecular model in Figure 9. This is likely to provide the driving 
force for the energetic rearrangement involving a high energy proton shift leading to the loss 
of dimethylmine.17 The planar structure will allow easy delocalisation of the charge, making 
the formation of the product ion thermodynamically favourable. 
 
The ion with an elemental formula of C15H15NO3S2+• (4) had a ring plus double bond 
equivalents value of 10 i.e. an odd-electron species.15 Figure 10 shows a proposed mechanism 
to form a radical product ion structure that is consistent with this value. Again, the posited 
product ion structure is predominately planar (Figure 11), thus allowing facile delocalisation 
of the charge, and also the radical site. This is particularly important due to the energetically 
unfavourable formation of a radical product ion from an even electron precursor.18 However, 
the resonance stabilisation across the two aromatic rings, and the sulfone and sulfoxide 
functionalities, is likely to facilitate this dissociation. 
 
Both proposed dissociation mechanisms involve the loss of dimethylamine. However, the 
pathways leading to this loss differ for the two product ions. The formation of 3 is postulated 
to involve the loss of dimethylamine facilitated by the shift of a non-exchangeable hydrogen 
atom. On the other hand, the formation of 4 proceeds via protonation of the tertiary amine 
followed by a charge-directed inductive cleavage of the carbon-nitrogen bond. Thus, an 
exchangeable hydrogen atom i.e. the ionising proton (deuteron), is proposed to facilitate the 
loss of dimethylamine in this instance. The loss of dimethylamine was also observed in the 
first generation product ion spectrum of protonated 1 (Figure 2; product ion at m/z 338). The 
dissociation of the fully exchanged, deuterated species (Figure 4) showed that the loss 
increased by 1 m/z unit to produce a peak at m/z 340, demonstrating the involvement of a 
single exchangeable hydrogen atom in the fragmentation. The protonated molecule can not be 
spatial arranged such that the two exchangeable hydrogen atoms on the primary amine can be 
in close proximity to the tertiary amine functionality to allow intramolecular transfer. Thus, 
they can be excluded as being the source of the exchangeable hydrogen atom involved in the 
loss of dimethylamine. Hence, the exchangeable hydrogen atom must be the ionising proton 
(deuteron). From the two mechanisms postulated for the losses of 62 m/z units (Figures 8 and 
10), only one involves protonation at the tertiary amine and the loss of dimethylamine 
facilitated by an exchangeable hydrogen atom i.e. the loss of C2H8NO•. Protonation at the 
primary amine is inferred for the loss of C2H10N2 to facilitate expulsion of a molecule of 
ammonia from the precursor ion. This could not be confirmed using H/D exchange 
experiments because the loss of ammonia is not observed in the first generation product ion 
spectrum of protonated 1 (Figure 2). However, supportive evidence for the proposed 
mechanisms was obtained through acquisition of the second generation product ion spectrum 
of fully exchanged, deuterated 1 using the ion at m/z 340 as the precursor ion for the second 
stage of mass analysis (Figure 12). The dissociation of the fully exchanged, deuterated 
molecule, rather than the protonated molecule, was investigated so that the product ions 
would be mass resolved on the QIT mass spectrometer if they were both formed. In the mass 
range of interest, a product ion was observed at m/z 323, which suggested that 4 is formed 
through protonation at the tertiary amine, followed by the loss of dimethylamine and then 
expulsion of a hydroxyl radical. The mass difference of 17 m/z units between the precursor 
ion for the second stage of mass analysis and the final product ion indicated that the loss of 
the hydroxyl radical involved a non-exchangeable hydrogen atom. If an exchangeable 
hydrogen atom was involved, under deuterated conditions the loss would become a 
deuterohydroxyl radical and the mass loss would increase to 18 m/z units. The observations 
were consistent with the proposed mechanism for the dissociation (Figure 10). No peak was 
observed at m/z 321, which indicated that a second dissociation pathway exists for the loss of 
dimethylamine. This provided supportive evidence for a loss of dimethylamine facilitated by 
the shift of a non-exchangeable hydrogen atom, which is consistent with the proposed 
mechanism (Figure 8). The absence of the loss of ammonia and dimethylamine facilitated by 
a non-exchangeable hydrogen atom in the first generation product ion spectrum of 
protonated 1 suggested that the dissociation was concerted, or at least the intermediates 
underwent rapid dissociation to the final product ion. Further, the H/D exchange experiments 
suggested that 1 had more than one site of protonation in the gas-phase because the loss of 
the tertiary amine group was not via protonation at that site in the formation of 3. Thus, it was 
plausible that the molecule could protonate at the primary amine, further supporting the 
mechanism proposal. 
The discussed dissociation has implications for structural elucidation using CID product ion 
spectra, particularly pharmaceutical drug metabolite identification studies. The structure of a 
metabolite must be deduced from its product ion spectrum. From the low resolution product 
ion spectrum of protonated 1, S-oxidation is likely to be proposed based upon the initial 
assignment of the 62 m/z units loss as methanethial, S-oxide via a four-centred 
rearrangement. In this case, the proposal of S-oxidation would have been correct, but the 
assignments of ions leading to this proposal would have been incorrect. If this were an 
unknown metabolite, oxidation of the parent compound could have occurred, for example, 
through aromatic hydroxylation of the 1-methyl-2-methylsulfanyl-benzene ring and 
potentially not affected either of the actual losses of 62 m/z units that took place. The 
attractive nature of S-oxidation facilitating the loss of methanethial, S-oxide via a four-
centred rearrangement may lead to mis-assignment of the ions in the CID spectrum. Hence 
time and money may be spent synthesising analogues and/or homologues to protect the 
methyl sulfide functionality of the parent compound only to discover that the hypothesised 
site of oxidation is incorrect. The discussed example highlights the possibility of unexpected 
rearrangements under CID conditions, which could easily lead to incorrect assignment of ion 
structure, and hence sites of metabolism in drug discovery studies. A simple and cost 
effective approach to reduce the likelihood of this occurrence is the use of H/D exchange 
experiments, which provide a straightforward method of introducing isotopic labels into the 
compound. Thus, dissociations proposed to involve exchangeable hydrogen atoms can be 
verified. Further, employment of mass spectrometers capable of high resolution, even when 
coupled to fast chromatography as utilised in metabolite identification studies, would also 
reduce the possibility of incorrect ion structure assignment. The study has also been of 
relevance to the understanding of fragmentation under CID conditions. The actual 
dissociations involved more complex rearrangements than that initially proposed, and also the 
energetically unfavourable formation of a radical product ion. However, the final shape of the 
product ion appears to have a bearing on the dissociation pathway followed. The initially 
proposed product ion structure formed through the loss of methanethial, S-oxide has free 
rotation about the ether linkage. The product ions actually formed are posited to be 
predominately planar, thus allowing easier delocalisation of the charge. This may suggest that 
the energetic favourability of the product ion structure can outweigh the facileness of the 
rearrangement and provide the driving force for dissociation; suggesting less dependence on 
the kinetics of the fragmentation under CID conditions compared to electron ionisation (EI) 
conditions.1 Furthermore, the study indicated that H/D exchange experiments can be useful in 
determining sites of gas-phase protonation under ESI-CID conditions, which has been 
demonstrated in a previous study19, thus allowing rationalisation of dissociation mechanisms. 
 
Conclusions 
The experimental investigation of the dissociation of a model S-oxidised metabolite has been 
presented. The ion at m/z 321 observed in the low resolution CID product ion spectrum was 
initially assigned as being formed through the loss of methanethial, S-oxide from the 
protonated molecule. It was thought that this loss could be used to assign the site of 
metabolism as the sulfur of the methyl sulfide group. Subsequent deuterium labelling 
experiments and accurate mass measurements acquired using a high resolution CID product 
ion spectrum proved that the initial assignment was incorrect. Instead, two unexpected 
rearrangements lead to the formation of nominally isobaric ions. Only through the use of H/D 
exchange experiments and high resolution mass spectrometry was it possible to mass resolve 
these species. Mechanisms consistent with the experimental findings were postulated and 
supportive evidence for the proposals was obtained through the acquisition of a second 
generation product ion spectrum. The proposed planar product ion structures were concluded 
to provide the driving force for the rearrangements, particularly in the formation of an 
energetically unfavourable radical cation. The study was of relevance to pharmaceutical drug 
metabolite identification because it demonstrated that a rigorous analytical approach is 
required to ensure that incorrect assignment of the sites of metabolism of novel chemical 
entities is precluded. A greater understanding of fragmentation under CID conditions was 
also obtained, with the shape of the product ion apparently offsetting the complexity of the 
rearrangement required to form it. Further, the data verified the usefulness of H/D exchange 
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Figure 4. First generation product ion spectrum of fully exchanged, deuterated 1 acquired using a LCQ Classic QIT mass spectrometer with 


































Figure 7. First generation product ion spectrum of protonated 1 acquired using an Apex III FT-ICR mass spectrometer 
 


























































Figure 12. Second generation product ion spectrum of fully exchanged, deuterated 1 using the ion at m/z 340 as the precursor ion for the second 
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Abstract 
S-oxidation is a common metabolic route for sulphur containing compounds. When studying 
the fragmentation of some chemically synthesised sulphoxides, two unexpected losses of 
62 m/z units were observed in the collision-induced dissociation (CID) product ion spectrum 
protonated 3-dimethylaminomethyl-4-(4-methanesulfinyl-3-methyl-phenoxy)-
benzenesulfonamide. A single loss was initially assigned using the low resolution product ion 
spectrum, acquired by electrospray ionisation-quadrupole ion trap-mass spectrometry (ESI-
QIT-MS), as methanethial, S-oxide with the dissociation proceeding via a charge-remote, 
four-centred rearrangement. This assignment was consistent with well-documented hydrogen 
rearrangements in the literature. Further, the loss was not observed for the parent compound. 
Thus, it was inferred that the site of metabolism was involved in the dissociation and the 
attractive nature of the four-centred rearrangement meant that the loss of methanethial, S-
oxide was a logical assignment. However, deuterium labelling experiments and accurate mass 
measurements, performed using electrospray ionisation-Fourier Transform Ion Cyclotron 
Resonance-mass spectrometry (ESI-FTICR-MS), showed that two distinct losses of 62 m/z 
units occur, neither of which was of that initially hypothesised from the low resolution 
product ion spectrum of the protonated molecule. Mechanisms consistent with the 
experimental findings are postulated. An MS3 spectrum of the fully exchanged, deuterated 
species supported the proposed mechanisms by suggesting that 3-dimethylaminomethyl-4-(4-
methanesulfinyl-3-methyl-phenoxy)-benzenesulfonamide has multiple sites of protonation in 
the gas phase. The planar structures of the posited product ions are likely to provide the 
driving force for the rearrangements. The relevance of the observations with regards to 
pharmaceutical drug metabolite identification are discussed. 
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Identification of the metabolites of pharmaceutical compounds is a key stage of drug 
discovery. Sites on the novel chemical entity prone to biotransformation are identified, thus 
allowing the pharmacokinetic behaviour of the molecule to be improved through alteration of 
the compound’s structure.1, 2 Active metabolites, i.e. those possessing pharmacological 
activity similar, synergistic or inhibitory to that of the parent compound, can be identified to 
rationalise pharmacodynamic results.3, 4 Additionally, novel chemical entities that form 
reactive metabolites, resulting in toxicity, can be identified and either modified or eliminated 
to prevent failure of the drug candidate in the development stage.5 
 
During early drug discovery metabolite identification studies, limited amounts of chemical 
bulk and the need for liquid chromatographic separation may prohibit the routine acquisition 
of nuclear magnetic resonance (NMR) spectra for definitive structural elucidation. Hence, 
mass spectrometry is routinely used to assign the sites of metabolism of pharmaceutical drug 
compounds. The principal method involves comparing the collision-induced dissociation 
(CID) product ion spectrum of the parent compound with that of the metabolite and looking 
for mass shifts of the major peaks in these spectra to determine which part of the molecule 
has been altered i.e. the Shift technique.6 However, unambiguous assignments by this 
approach are frequently not possible, particularly for oxidised metabolites where the 
biotransformation can take place at carbon, nitrogen or sulfur atoms; all common constituents 
of pharmaceutical compounds.7 Furthermore, the high-throughput nature of modern drug 
discovery means that multiple mass spectrometric-related structural elucidation experiments 
e.g. deuterium labelling, derivatisation etc., are rarely performed. Thus, there is a risk that 
incorrect assignment of sites of metabolism could arise. This is a particular likelihood given 
that the CID processes for molecules of this type are still not fully understood, with 
unexpected rearrangements under CID conditions being previously reported in the literature 
for both small and peptidic molecules.8-11 Herein, a further example of unanticipated 
dissociation behaviour, observed for the model sulfoxide detailed here, demonstrates how 
incorrect assignment of the sites of metabolism of a novel chemical entity could occur if a 









benzenesulfonamide (2) were synthesised by Pfizer Global Research and Development 
(Sandwich, UK). Reserpine was purchased from Sigma-Aldrich Company Limited 
(Gillingham, Dorset, UK). Solutions were prepared in LC-MS grade methanol and analytical 
grade methanoic acid [99.9:0.1, v/v] (Fisher Scientific UK Limited, Loughborough, UK). 
Solutions of 1 and 2 were prepared at 10 µg mL-1 for the quadrupole ion trap mass 
spectrometry (QIT-MS) experiments. Further solutions of 1 were prepared at 1 µg mL-1 for 
the Fourier transform ion cyclotron resonance-mass spectrometry (FT-ICR-MS) experiments 
and 10 µg mL-1 in >99.5% deuterated methanol and 99.5% deuterated ethanoic acid 
[99:1, v/v] (Apollo Scientific Limited, Stockport, UK) for hydrogen/deuterium (H/D) 
exchange experiments. All chemicals were used without further purification. 
 
Instrumental 
Product ion spectra of either the protonated or fully, exchanged deuterated molecule for each 
compound were acquired using a LCQ Classic QIT mass spectrometer (Thermo Fisher 
Scientific, San Jose, CA, USA). Positive ion electrospray (ESI) was performed by infusing 
the solutions directly into the source at a constant flow rate of 3 µL min-1. Nitrogen was used 
as the sheath and auxiliary gas. The source conditions were; sheath gas, 35 arbitrary units; 
auxiliary gas, 5 arbitrary units; spray voltage, 4.5 kV; capillary voltage, 11 V; capillary 
temperature, 220 oC; tube lens offset, 35 V. Product ion spectra were acquired using an 
isolation width of 6 m/z units (1 m/z unit for the H/D exchange experiments), an activation Q 
of 0.250 and an activation time of 30 msec. The normalised collision energy was set to 50% 
and WideBand activation was switched on. Acquisitions were performed for twenty scans. 
Helium was used as the buffer gas. Data acquisition was performed using XCalibur version 
1.2 (Thermo Fisher Scientific, San Jose, CA, USA). 
 
Accurate mass measurements were performed using an Apex III FT-ICR mass spectrometer 
(Bruker, Billerica, MA, USA) equipped with a 4.7 Tesla actively shielded superconducting 
magnet, an Infinity cylindrical analyser cell and an Apollo ESI source. Positive ion ESI was 
performed by infusing the solutions directly into the source at a constant flow rate of 
3 µL min-1. Nitrogen was used as the drying gas. The source conditions were; capillary 
voltage, -4.5 kV; end plate voltage, -3.8 kV; capillary exit voltage, 100 V; skimmer 1, 11 V; 
skimmer 2, 6 V; Offset, 1.25; Rf amplitude, 600 Hz; dry gas temperature, 250 oC; dry gas 
flow rate, 30 arbitrary units; nebulising gas pressure, 50 psi. The excitation amplitude was 
3.7 dB. The product ion spectra were acquired for eight scans using 1024K data points. 
Argon was used as the collision gas. The MS/MS parameters were; corr sweep pulse length, 
1000 µsec; corr sweep attenuation, 37.5 dB; ejection safety belt, 3000 Hz; user pulse length, 
1000 µsec; ion activation pulse length, 250000 µsec; ion activation attenuation, 37.2 dB; 
frequency offset from activation mass, - 500 Hz; user delay length, 3 sec. The instrument was 
calibrated using the first-generation product ion spectrum of protonated reserpine. The 
calibrant concentration was 100 ng mL-1 and the solution was infused directly into the ESI 
source at a constant flow rate of 3 µL min-1. Data acquisition was performed using XMass 
version 7.0.8 (Bruker, Billerica, MA, USA). 
 
Results and discussion 
During a project to identify product ions and losses that facilitate rapid and definitive 
identification of pharmaceutical drug metabolites, the dissociation of a model S-oxidised 
metabolite, 3-dimethylaminomethyl-4-(4-methanesulfinyl-3-methyl-phenoxy)-
benzenesulfonamide (1) (Figure 1), was investigated. The first generation product ion 
spectrum of the protonated molecule is shown in Figure 2. It was hypothesised that the ion at 
m/z 321 was due to the loss of the methyl sulfoxide group. Thus, the dissociation was thought 
to be of potential use in metabolite identification; the 62 m/z unit loss being assigned as 
methanethial, S-oxide (CH2SO). S-oxidation of the parent compound produces an ideal 
candidate for the loss of 62 m/z units through the well-documented processes of charge-
remote fragmentation12 and 1,3-proton shifts13 via four-centred rearrangements (Figure 3). 
This hypothesis was further attractive due to the absence of the same 62 m/z unit loss from 
the parent compound (data not shown). Thus, it was postulated that the loss involved the 
oxygen atom. The dissociation was thought to be energetically favourable due to the 
conformance of the postulated product ion with the even-electron rule.14 However, the loss 
could not be confirmed by a change in the 34S isotope pattern for the product ion compared to 
the precursor ion due to the difficulties associated with observing the true isotope pattern 
using a QIT mass spectrometer. The overlapping of the A + 2 peak with the peak due to the 
lightest isotopes of the product ion at m/z 323 further precluded this approach to structural 
elucidation. 
 
It was noted that the 62 m/z unit loss involved none of the three exchangeable hydrogen 
atoms on the precursor ion. Thus, if the assignment of the loss was correct, the m/z of the 
product ion would shift by 3 m/z units to m/z 324 in the product ion spectrum of the fully 
exchanged, deuterated species (Figure 4). The absence of a peak at m/z 324 in the deuterated 
sample indicated that the initially posited loss was incorrect. Further, an additional peak was 
observed at m/z 323 in the product ion spectrum of the fully, exchanged deuterated species 
that was not seen for the protonated molecule. It should be noted that this ion was different to 
that seen at m/z 323 in the product ion spectrum of the protonated molecule, which was mass 
shifted to m/z 325 under deuterated conditions. The observation of an additional peak led to 
the deduction that two nominally isobaric product ions were formed through dissociation of 
the protonated species. The product ions only became mass resolved when the fully 
exchanged, deuterated molecule was fragmented due to the retention of different numbers of 
deuterium atoms by the two product ions. Thus, the H/D exchange experiment showed that 
two losses of 62 m/z units took place, neither of which was that initially postulated. The loss 
of all of the deuterium atoms to form the product ion at m/z 321 indicated that the primary 
amine group had been lost during the dissociation. This was because exchange of two 
hydrogen atoms for deuterium labels would have occurred at this functional group. The peak 
at m/z 323, formed through a loss involving one deuterium atom, indicated that this product 
ion retained the primary amine. Further, it suggested that the ionising deuteron was lost 
during the dissociation, and hence the loss included a site of ionisation. 
 
Further experimentation was undertaken to characterise the two losses of 62 m/z units. To this 
end, the first generation product ion spectrum of a deuterium labelled analogue, 3-dimethyl-
2H6-aminomethyl-4-(4-methanesulfinyl-3-methyl-phenoxy)-benzenesulfonamide (2) (Figure 
5), was acquired (Figure 6). In the mass range of interest, the product ion spectrum resembled 
that of protonated 1 with only two peaks being observed. This indicated that the product ions 
were nominally isobaric again and neither product ion retained the six deuterium labels. 
Thus, both losses of 62 m/z units involved the tertiary amine group. The H/D exchange 
experiment had shown that one product ion also lost the primary amine group; thus the 
overall loss was postulated to be C2H10N2. The same experiment had also shown that one 
product ion retained the primary amine and lost the ionising deuteron. From this information, 
it was deduced that the tertiary amine group was a site of protonation. Further, it suggested 
that the remaining loss of 17 m/z units for the product ion that retained the primary amine 
group (62 m/z units minus 45 m/z units for the tertiary amine group plus the ionising proton) 
was likely to be a hydroxyl radical; an overall proposed loss of C2H8NO•. 
 
To confirm the hypothesised losses, accurate mass measurements were performed using 
Fourier transform-ion cyclotron resonance (FT-ICR) mass spectrometry. Figure 7 shows the 
first generation product ion spectrum of protonated 1 in the mass range of interest. The high 
resolving power of the FT-ICR mass spectrometer allowed mass resolution of the two 
nominally isobaric ions at m/z 321. The lowest error elemental formulae, given the precursor 
ion formula, were consistent with those postulated and confirmed that the two losses of 
62 m/z units were C2H10N2 and C2H8NO•. 
 
The verification of the elemental composition of the losses allowed postulation of 
dissociation mechanisms leading to the decomposition of the precursor ion. The ion with an 
elemental formula of C15H13O4S2+ (3) had a ring plus double bond equivalents value of 9.5, 
confirming that it was an even-electron ion.15 Because of the deficiency of this value by 0.5 
due to the addition of a proton to the molecule16, the number of rings plus double bond 
equivalents in the product ion must have been 10. Figure 8 shows a proposed mechanism 
leading to the formation of a product ion which satisfies this value; the double bonds of the 
sulfone group are discounted due to sulfur not being in its lowest valence state.15 Protonation 
is postulated on the primary amine to facilitate the loss of the two exchangeable hydrogen 
atoms as part of a molecule of ammonia. The posited product ion structure is predominately 
planar as evinced by the molecular model in Figure 9. This is likely to provide the driving 
force for the energetic rearrangement involving a high energy proton shift leading to the loss 
of dimethylmine.17 The planar structure will allow easy delocalisation of the charge, making 
the formation of the product ion thermodynamically favourable. 
 
The ion with an elemental formula of C15H15NO3S2+• (4) had a ring plus double bond 
equivalents value of 10 i.e. an odd-electron species.15 Figure 10 shows a proposed mechanism 
to form a radical product ion structure that is consistent with this value. Again, the posited 
product ion structure is predominately planar (Figure 11), thus allowing facile delocalisation 
of the charge, and also the radical site. This is particularly important due to the energetically 
unfavourable formation of a radical product ion from an even electron precursor.18 However, 
the resonance stabilisation across the two aromatic rings, and the sulfone and sulfoxide 
functionalities, is likely to facilitate this dissociation. 
 
Both proposed dissociation mechanisms involve the loss of dimethylamine. However, the 
pathways leading to this loss differ for the two product ions. The formation of 3 is postulated 
to involve the loss of dimethylamine facilitated by the shift of a non-exchangeable hydrogen 
atom. On the other hand, the formation of 4 proceeds via protonation of the tertiary amine 
followed by a charge-directed inductive cleavage of the carbon-nitrogen bond. Thus, an 
exchangeable hydrogen atom i.e. the ionising proton (deuteron), is proposed to facilitate the 
loss of dimethylamine in this instance. The loss of dimethylamine was also observed in the 
first generation product ion spectrum of protonated 1 (Figure 2; product ion at m/z 338). The 
dissociation of the fully exchanged, deuterated species (Figure 4) showed that the loss 
increased by 1 m/z unit to produce a peak at m/z 340, demonstrating the involvement of a 
single exchangeable hydrogen atom in the fragmentation. The protonated molecule can not be 
spatial arranged such that the two exchangeable hydrogen atoms on the primary amine can be 
in close proximity to the tertiary amine functionality to allow intramolecular transfer. Thus, 
they can be excluded as being the source of the exchangeable hydrogen atom involved in the 
loss of dimethylamine. Hence, the exchangeable hydrogen atom must be the ionising proton 
(deuteron). From the two mechanisms postulated for the losses of 62 m/z units (Figures 8 and 
10), only one involves protonation at the tertiary amine and the loss of dimethylamine 
facilitated by an exchangeable hydrogen atom i.e. the loss of C2H8NO•. Protonation at the 
primary amine is inferred for the loss of C2H10N2 to facilitate expulsion of a molecule of 
ammonia from the precursor ion. This could not be confirmed using H/D exchange 
experiments because the loss of ammonia is not observed in the first generation product ion 
spectrum of protonated 1 (Figure 2). However, supportive evidence for the proposed 
mechanisms was obtained through acquisition of the second generation product ion spectrum 
of fully exchanged, deuterated 1 using the ion at m/z 340 as the precursor ion for the second 
stage of mass analysis (Figure 12). The dissociation of the fully exchanged, deuterated 
molecule, rather than the protonated molecule, was investigated so that the product ions 
would be mass resolved on the QIT mass spectrometer if they were both formed. In the mass 
range of interest, a product ion was observed at m/z 323, which suggested that 4 is formed 
through protonation at the tertiary amine, followed by the loss of dimethylamine and then 
expulsion of a hydroxyl radical. The mass difference of 17 m/z units between the precursor 
ion for the second stage of mass analysis and the final product ion indicated that the loss of 
the hydroxyl radical involved a non-exchangeable hydrogen atom. If an exchangeable 
hydrogen atom was involved, under deuterated conditions the loss would become a 
deuterohydroxyl radical and the mass loss would increase to 18 m/z units. The observations 
were consistent with the proposed mechanism for the dissociation (Figure 10). No peak was 
observed at m/z 321, which indicated that a second dissociation pathway exists for the loss of 
dimethylamine. This provided supportive evidence for a loss of dimethylamine facilitated by 
the shift of a non-exchangeable hydrogen atom, which is consistent with the proposed 
mechanism (Figure 8). The absence of the loss of ammonia and dimethylamine facilitated by 
a non-exchangeable hydrogen atom in the first generation product ion spectrum of 
protonated 1 suggested that the dissociation was concerted, or at least the intermediates 
underwent rapid dissociation to the final product ion. Further, the H/D exchange experiments 
suggested that 1 had more than one site of protonation in the gas-phase because the loss of 
the tertiary amine group was not via protonation at that site in the formation of 3. Thus, it was 
plausible that the molecule could protonate at the primary amine, further supporting the 
mechanism proposal. 
The discussed dissociation has implications for structural elucidation using CID product ion 
spectra, particularly pharmaceutical drug metabolite identification studies. The structure of a 
metabolite must be deduced from its product ion spectrum. From the low resolution product 
ion spectrum of protonated 1, S-oxidation is likely to be proposed based upon the initial 
assignment of the 62 m/z units loss as methanethial, S-oxide via a four-centred 
rearrangement. In this case, the proposal of S-oxidation would have been correct, but the 
assignments of ions leading to this proposal would have been incorrect. If this were an 
unknown metabolite, oxidation of the parent compound could have occurred, for example, 
through aromatic hydroxylation of the 1-methyl-2-methylsulfanyl-benzene ring and 
potentially not affected either of the actual losses of 62 m/z units that took place. The 
attractive nature of S-oxidation facilitating the loss of methanethial, S-oxide via a four-
centred rearrangement may lead to mis-assignment of the ions in the CID spectrum. Hence 
time and money may be spent synthesising analogues and/or homologues to protect the 
methyl sulfide functionality of the parent compound only to discover that the hypothesised 
site of oxidation is incorrect. The discussed example highlights the possibility of unexpected 
rearrangements under CID conditions, which could easily lead to incorrect assignment of ion 
structure, and hence sites of metabolism in drug discovery studies. A simple and cost 
effective approach to reduce the likelihood of this occurrence is the use of H/D exchange 
experiments, which provide a straightforward method of introducing isotopic labels into the 
compound. Thus, dissociations proposed to involve exchangeable hydrogen atoms can be 
verified. Further, employment of mass spectrometers capable of high resolution, even when 
coupled to fast chromatography as utilised in metabolite identification studies, would also 
reduce the possibility of incorrect ion structure assignment. The study has also been of 
relevance to the understanding of fragmentation under CID conditions. The actual 
dissociations involved more complex rearrangements than that initially proposed, and also the 
energetically unfavourable formation of a radical product ion. However, the final shape of the 
product ion appears to have a bearing on the dissociation pathway followed. The initially 
proposed product ion structure formed through the loss of methanethial, S-oxide has free 
rotation about the ether linkage. The product ions actually formed are posited to be 
predominately planar, thus allowing easier delocalisation of the charge. This may suggest that 
the energetic favourability of the product ion structure can outweigh the facileness of the 
rearrangement and provide the driving force for dissociation; suggesting less dependence on 
the kinetics of the fragmentation under CID conditions compared to electron ionisation (EI) 
conditions.1 Furthermore, the study indicated that H/D exchange experiments can be useful in 
determining sites of gas-phase protonation under ESI-CID conditions, which has been 
demonstrated in a previous study19, thus allowing rationalisation of dissociation mechanisms. 
 
Conclusions 
The experimental investigation of the dissociation of a model S-oxidised metabolite has been 
presented. The ion at m/z 321 observed in the low resolution CID product ion spectrum was 
initially assigned as being formed through the loss of methanethial, S-oxide from the 
protonated molecule. It was thought that this loss could be used to assign the site of 
metabolism as the sulfur of the methyl sulfide group. Subsequent deuterium labelling 
experiments and accurate mass measurements acquired using a high resolution CID product 
ion spectrum proved that the initial assignment was incorrect. Instead, two unexpected 
rearrangements lead to the formation of nominally isobaric ions. Only through the use of H/D 
exchange experiments and high resolution mass spectrometry was it possible to mass resolve 
these species. Mechanisms consistent with the experimental findings were postulated and 
supportive evidence for the proposals was obtained through the acquisition of a second 
generation product ion spectrum. The proposed planar product ion structures were concluded 
to provide the driving force for the rearrangements, particularly in the formation of an 
energetically unfavourable radical cation. The study was of relevance to pharmaceutical drug 
metabolite identification because it demonstrated that a rigorous analytical approach is 
required to ensure that incorrect assignment of the sites of metabolism of novel chemical 
entities is precluded. A greater understanding of fragmentation under CID conditions was 
also obtained, with the shape of the product ion apparently offsetting the complexity of the 
rearrangement required to form it. Further, the data verified the usefulness of H/D exchange 
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Figure 4. First generation product ion spectrum of fully exchanged, deuterated 1 acquired using a LCQ Classic QIT mass spectrometer with 


































Figure 7. First generation product ion spectrum of protonated 1 acquired using an Apex III FT-ICR mass spectrometer 
 


























































Figure 12. Second generation product ion spectrum of fully exchanged, deuterated 1 using the ion at m/z 340 as the precursor ion for the second 
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